Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, Virginia.
Department of Cell Biology, University of Virginia, Charlottesville, Virginia.
Cancer Res. 2019 Jul 15;79(14):3662-3675. doi: 10.1158/0008-5472.CAN-18-3464. Epub 2019 May 7.
It is unknown why some patients with hormone receptor-positive (HR) breast cancer present with more aggressive and invasive disease. Metastatic dissemination occurs early in disease and is facilitated by cross-talk between the tumor and tissue environment, suggesting that undefined host-intrinsic factors enhance early dissemination and the probability of developing metastatic disease. Here, we have identified commensal dysbiosis as a host-intrinsic factor associated with metastatic dissemination. Using a mouse model of HR mammary cancer, we demonstrate that a preestablished disruption of commensal homeostasis results in enhanced circulating tumor cells and subsequent dissemination to the tumor-draining lymph nodes and lungs. Commensal dysbiosis promoted early inflammation within the mammary gland that was sustained during HR mammary tumor progression. Furthermore, dysbiosis enhanced fibrosis and collagen deposition both systemically and locally within the tumor microenvironment and induced significant myeloid infiltration into the mammary gland and breast tumor. These effects were recapitulated both by directly targeting gut microbes using nonabsorbable antibiotics and by fecal microbiota transplantation of dysbiotic cecal contents, demonstrating the direct impact of gut dysbiosis on mammary tumor dissemination. This study identifies dysbiosis as a preexisting, host-intrinsic regulator of tissue inflammation, myeloid recruitment, fibrosis, and dissemination of tumor cells in HR breast cancer. SIGNIFICANCE: Identification of commensal dysbiosis as a host-intrinsic factor mediating evolution of metastatic breast cancer allows for development of interventions or diagnostic tools for patients at highest risk for developing metastatic disease..
目前尚不清楚为什么一些激素受体阳性(HR)乳腺癌患者表现出更具侵袭性和侵略性的疾病。转移扩散在疾病早期发生,并受到肿瘤与组织环境之间相互作用的促进,这表明未定义的宿主内在因素增强了早期扩散和发生转移性疾病的可能性。在这里,我们已经确定共生失调是与转移扩散相关的宿主内在因素。使用 HR 乳腺肿瘤的小鼠模型,我们证明预先存在的共生平衡破坏会导致循环肿瘤细胞增加,并随后扩散到肿瘤引流淋巴结和肺部。共生失调促进了乳腺内的早期炎症,这种炎症在 HR 乳腺肿瘤进展过程中持续存在。此外,失调会增强系统性和肿瘤微环境局部的纤维化和胶原沉积,并诱导骨髓细胞大量浸润乳腺和乳腺肿瘤。这些效应既可以通过使用不可吸收的抗生素直接靶向肠道微生物来再现,也可以通过移植失调的盲肠内容物的粪便微生物群来再现,这表明肠道失调对乳腺肿瘤扩散有直接影响。这项研究确定了失调是 HR 乳腺癌中组织炎症、髓样细胞募集、纤维化和肿瘤细胞转移的预先存在的宿主内在调节剂。意义:将共生失调鉴定为介导转移性乳腺癌演变的宿主内在因素,为处于发生转移性疾病最高风险的患者开发干预或诊断工具提供了可能。